News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
735,041 Results
Type
Article (77377)
Company Profile (344)
Press Release (657320)
Multimedia
Podcasts (109)
Webinars (14)
Section
Business (194506)
Career Advice (3289)
Deals (36126)
Drug Delivery (128)
Drug Development (86545)
Employer Resources (182)
FDA (16832)
Job Trends (15796)
News (344179)
Policy (35075)
Tag
Academia (2994)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (93)
Alliances (49919)
ALS (99)
Alzheimer's disease (1493)
Antibody-drug conjugate (ADC) (153)
Approvals (16796)
Artificial intelligence (290)
Autoimmune disease (28)
Automation (15)
Bankruptcy (352)
Best Places to Work (12197)
BIOSECURE Act (21)
Biosimilars (119)
Biotechnology (239)
Bladder cancer (84)
Brain cancer (32)
Breast cancer (298)
Cancer (2404)
Cardiovascular disease (203)
Career advice (2788)
Career pathing (34)
CAR-T (172)
Cell therapy (468)
Cervical cancer (21)
Clinical research (69961)
Collaboration (897)
Compensation (538)
Complete response letters (30)
COVID-19 (2855)
CRISPR (48)
C-suite (263)
Cystic fibrosis (105)
Data (2251)
Decentralized trials (2)
Denatured (32)
Depression (54)
Diabetes (296)
Diagnostics (6671)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (43)
Drug discovery (128)
Drug pricing (124)
Drug shortages (33)
Duchenne muscular dystrophy (101)
Earnings (73568)
Editorial (44)
Employer branding (25)
Employer resources (158)
Events (106681)
Executive appointments (771)
FDA (18129)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (802)
Gene editing (119)
Generative AI (26)
Gene therapy (347)
GLP-1 (844)
Government (4993)
Grass and pollen (6)
Guidances (58)
Healthcare (20321)
Huntington's disease (25)
IgA nephropathy (31)
Immunology and inflammation (146)
Indications (30)
Infectious disease (3014)
Inflammatory bowel disease (152)
Inflation Reduction Act (10)
Influenza (55)
Intellectual property (101)
Interviews (618)
IPO (17040)
IRA (50)
Job creations (4031)
Job search strategy (2298)
Kidney cancer (11)
Labor market (35)
Layoffs (545)
Leadership (24)
Legal (8430)
Liver cancer (79)
Lung cancer (344)
Lymphoma (158)
Machine learning (7)
Management (63)
Manufacturing (336)
MASH (74)
Medical device (14074)
Medtech (14079)
Mergers & acquisitions (19675)
Metabolic disorders (778)
Multiple sclerosis (87)
NASH (23)
Neurodegenerative disease (111)
Neuropsychiatric disorders (34)
Neuroscience (2090)
NextGen: Class of 2025 (7310)
Non-profit (5004)
Now hiring (37)
Obesity (418)
Opinion (274)
Ovarian cancer (78)
Pain (97)
Pancreatic cancer (86)
Parkinson's disease (160)
Partnered (23)
Patents (248)
Patient recruitment (114)
Peanut (51)
People (58577)
Pharmaceutical (78)
Pharmacy benefit managers (21)
Phase I (21492)
Phase II (30500)
Phase III (23077)
Pipeline (1229)
Policy (166)
Postmarket research (3215)
Preclinical (9508)
Press Release (70)
Prostate cancer (111)
Psychedelics (38)
Radiopharmaceuticals (264)
Rare diseases (424)
Real estate (6302)
Recruiting (73)
Regulatory (23942)
Reports (42)
Research institute (2618)
Resumes & cover letters (522)
Rett syndrome (5)
RNA editing (5)
RSV (50)
Schizophrenia (80)
Series A (142)
Series B (91)
Service/supplier (17)
Sickle cell disease (57)
Special edition (18)
Spinal muscular atrophy (165)
Sponsored (34)
Startups (3927)
State (2)
Stomach cancer (15)
Supply chain (75)
Tariffs (43)
The Weekly (75)
Vaccines (804)
Venture capitalists (42)
Weight loss (299)
Women's health (38)
Worklife (20)
Date
Today (167)
Last 7 days (878)
Last 30 days (2715)
Last 365 days (34055)
2025 (11024)
2024 (36533)
2023 (41413)
2022 (52634)
2021 (57289)
2020 (56130)
2019 (49974)
2018 (38045)
2017 (35104)
2016 (34562)
2015 (39753)
2014 (32026)
2013 (30864)
2012 (30048)
2011 (30407)
2010 (29075)
Location
Africa (1060)
Alabama (53)
Alaska (7)
Arizona (191)
Arkansas (14)
Asia (44243)
Australia (7888)
California (6136)
Canada (2002)
China (556)
Colorado (274)
Connecticut (287)
Delaware (151)
Europe (103194)
Florida (917)
Georgia (199)
Hawaii (1)
Idaho (63)
Illinois (579)
India (28)
Indiana (313)
Iowa (10)
Japan (167)
Kansas (109)
Kentucky (24)
Louisiana (13)
Maine (62)
Maryland (913)
Massachusetts (4618)
Michigan (225)
Minnesota (394)
Mississippi (2)
Missouri (92)
Montana (31)
Nebraska (24)
Nevada (65)
New Hampshire (69)
New Jersey (1747)
New Mexico (31)
New York (1752)
North Carolina (1086)
North Dakota (9)
Northern California (2671)
Ohio (212)
Oklahoma (15)
Oregon (37)
Pennsylvania (1388)
Puerto Rico (12)
Rhode Island (36)
South America (1406)
South Carolina (22)
South Dakota (1)
Southern California (2289)
Tennessee (102)
Texas (933)
United States (23465)
Utah (182)
Virginia (159)
Washington D.C. (68)
Washington State (573)
West Virginia (3)
Wisconsin (53)
735,041 Results for "st louis university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
GLP-1
The Good, the Bad and the Ugly of GLP-1s: Study
Computational research conducted by scientists from Washington University in St. Louis shows that GLP-1 agonists can have mental and cognitive health benefits but may also harm the kidneys and pancreas.
January 21, 2025
·
2 min read
·
Dan Samorodnitsky
Job Trends
Thermo Fisher Scientific Expands St. Louis Manufacturing for Complex Biologic Treatments
Thermo Fisher Scientific, the world leader in serving science, today expanded its manufacturing capacity in St. Louis to support biologic therapies for diseases ranging from cancers to auto immune conditions to rare genetic disorders.
October 5, 2023
·
3 min read
Press Releases
Junshi Biosciences Announces the sNDA Approval of Toripalimab for the 1st-line Treatment of Melanoma
April 28, 2025
·
8 min read
Bio NC
Asensus Surgical Announces St. Marianna University School of Medicine Yokohama City Seibu Hospital in Japan to Initiate Senhance Surgery Program
Asensus Surgical, Inc. announced that St. Marianna University School of Medicine Yokohama City Seibu Hospital in Japan has entered into an agreement to lease and utilize a Senhance® Surgical System in the Urology and Gastroenterology/General Surgery department.
June 24, 2024
·
5 min read
Press Releases
Johnson & Johnson to Participate in the Bernstein’s 41st Annual Strategic Decisions Conference
April 28, 2025
·
1 min read
Covalon Announces Participation in Oley Conference in St. Louis, Missouri on June 27 – 30, 2023
Covalon Announces Participation in Oley Conference in St. Louis, Missouri on June 27 – 30, 2023.
June 27, 2023
·
7 min read
Interventional DiviTum(R) TKa Trial Launches at Washington University
Biovica, active in blood-based cancer monitoring, announces that a clinical trial, BettER, is being launched at Washington University School of Medicine in St. Louis.
March 13, 2024
·
2 min read
Press Releases
Aligos Therapeutics to Announce 1st Quarter 2025 Financial Results on May 6, 2025
April 30, 2025
·
2 min read
Business
Sensei Biotherapeutics Announces Collaboration with Washington University, St. Louis to Support Development of SNS-101
Sensei Biotherapeutics, Inc. today announced it has entered into a Sponsored Research Agreement with Washington University in St. Louis, MO, to support development of SNS-101, a conditionally active VISTA-blocking antibody.
November 21, 2022
·
5 min read
BioMidwest
The Retina Center of St. Louis County Applauds Data Confirming Dietary Oral Zeaxanthin Decreases the Progression of Wet Age-Related Macular Degeneration
The Retina Center of St. Louis County is excited to share recent data that was published in the peer-reviewed journal Ophthalmology and Therapy, titled Prevention Surpasses Treatment: 5-year Follow-Up, Cost-Utility, and Cost-Benefit of Zeaxanthin Therapy for Neovascular Age-Related Macular Degeneration.
September 12, 2023
·
3 min read
1 of 73,505
Next
